Pay Attention to this Trade Activity as Dermata Therapeutics Inc. (DRMA) last week performance was -12.37%


Dermata Therapeutics Inc. (NASDAQ: DRMA) open the trading on November 23, 2022, with a bit cautious approach as it glided -5.97% to $0.64. During the day, the stock rose to $0.6801 and sunk to $0.62 before settling in for the price of $0.69 at the close. Taking a more long-term approach, DRMA posted a 52-week range of $0.44-$3.19.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Nevertheless, stock’s Earnings Per Share (EPS) this year is -223.30%. This publicly-traded company’s shares outstanding now amounts to $12.10 million, simultaneously with a float of $8.09 million. The organization now has a market capitalization sitting at $8.23 million. At the time of writing, stock’s 50-day Moving Average stood at $0.6368, while the 200-day Moving Average is $0.8097.

Dermata Therapeutics Inc. (DRMA) Ownership Facts and Figures

Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Dermata Therapeutics Inc.’s current insider ownership accounts for 2.00%, in contrast to 1.60% institutional ownership.

Dermata Therapeutics Inc. (DRMA) Earnings and Revenue Records

So, what does the last quarter earnings report of the company that was made public on 6/29/2022 suggests? It has posted -$0.24 earnings per share (EPS) beating the forecaster’s viewpoint (set at -$0.32) by $0.08. This company achieved a return on equity of -228.09. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.

Dermata Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -223.30% and is forecasted to reach -1.11 in the upcoming year.

Dermata Therapeutics Inc. (NASDAQ: DRMA) Trading Performance Indicators

Let’s observe the current performance indicators for Dermata Therapeutics Inc. (DRMA). The Stock has managed to achieve an average true range (ATR) of 0.07.

In the same vein, DRMA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.40, a figure that is expected to reach -0.20 in the next quarter, and analysts are predicting that it will be -1.11 at the market close of one year from today.

Technical Analysis of Dermata Therapeutics Inc. (DRMA)

[Dermata Therapeutics Inc., DRMA] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 55.73% While, its Average True Range was 0.0676.


Please enter your comment!
Please enter your name here